Healthcare
Live Price
Offline$4.10
+0.00% today
1Y Change
—
Window
No data
Historical coverage is still loading
We are still backfilling 1Y daily history for this symbol. Some charts may stay empty until more data arrives.
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
McKesson Europe AG (CAKFY) is a Healthcare stock with a market cap of $5.37B. The stock last traded around $4.10. Baseline metrics include revenue growth of -44.7%, EPS growth of -5500.0%, a dividend yield of 0.0%. What stands out right now is revenue -44.7%, EPS -5500.0%, free cash flow -99.7% with operating margin 0.6% and ROIC 2.1%. Valuation is more restrained than many high-expectation growth names at price/sales 0.5. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines CAKFY price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Benchmark Comparison
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
CAKFY
—
Normalized return
SPY
—
S&P 500
Excess Return
—
Relative to SPY
CAKFY Max Drawdown
—
Trailing 1Y
SPY Max Drawdown
—
Trailing 1Y
Uses the longest available daily history for CAKFY and SPY.
Financial profile
Profitability, balance sheet stamina, and cash efficiency drawn from the latest filings.
FY Revenue
$21.1B
-0.4% YoY
FY Net Income
-$299.0M
-406.8% YoY
Free Cash Flow
$138.0M
-60.0% YoY
Revenue Growth
-44.7%
EPS Growth
-5500.0%
Gross Margin
8.7%
Net Margin
-0.5%
Income statement
EUR
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Revenue | 9.3B | 16.7B | 17.1B | 21.2B | 21.1B |
| Gross Profit | 804M | 1.8B | 1.9B | 2.0B | 2.1B |
| Operating Income | 59M | 132M | 119M | 24M | -285M |
| EBITDA | 219M | 357M | 170M | 183M | 180M |
| Net Income | -49M | 900K | -66M | -59M | -299M |
| EPS (Diluted) | — | — | — | — | — |
Balance sheet
EUR
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|
| Cash & Equivalents | 5M | 1.2B | 970M | 827M | 796M |
| Total Assets | 5.1B | 7.0B | 7.9B | 7.1B | 6.9B |
| Total Liabilities | 2.6B | 5.1B | 6.2B | 5.1B | 5.0B |
| Shareholder Equity | 2.5B | 1.9B | 1.7B | 2.0B | 1.9B |
| Total Debt | 184M | 544M | 587M | 19M | 24M |
| Net Debt | 179M | -642M | -383M | -808M | -772M |
Cash flow positioning
Latest Full Year
Operating Cash Flow
266M
-22.9% YoY
Capital Expenditures
128M
Free Cash Flow
138M
-60.0% YoY
Key ratios
Gross Margin
8.7%
Operating Margin
0.6%
Net Margin
-0.5%
ROE
-2.3%
Debt / Equity
0.07x
Next Step
Use the numbers to decide whether this is a growth candidate, a quality compounder, or just an interesting outlier.